Hugo R Lara-Martinez: Acute Immune Thrombocytopenia Following First Obinutuzumab Exposure
Hugo R Lara-Martinez, Former Assistant Professor of Medicine-Hematology at MD Anderson Cancer Center, shared a post on LinkedIn about a recent article he and Judy Al-Sayyad co-authored, published in Blood Vessels, Thrombosis and Hemostasis, adding:
“Excited to share our recently published case report, ‘Immune-Mediated Acute Thrombocytopenia Within 30 Minutes of First Obinutuzumab Infusion,’ in Blood Vessels, Thrombosis and Hemostasis.
We describe a rare but potentially serious complication of obinutuzumab, with profound thrombocytopenia developing shortly after the first infusion.
This case highlights the importance of recognizing obinutuzumab-induced acute thrombocytopenia and distinguishing it from other causes of thrombocytopenia in patients receiving anti-CD20 therapy.
A great collaboration with Judy Al-Sayyad and an important clinical reminder that sometimes the timing of an adverse event provides the biggest clue to the diagnosis.”
Title: Immune-mediated acute thrombocytopenia within 30 minutes of first obinutuzumab infusion
Authors: Judy Al-Sayyad, Hugo R Lara-Martinez
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 27, 2026, 16:28Rose Agor: Celebrating Two New Publications in Haematology Research
-
Oct 27, 2026, 16:21Pregnancy and Thrombosis-What Clinicians Need to Know – World Thrombosis Day
-
Oct 27, 2026, 16:13Lesley Van Wyk: DIC vs TTP vs HUS – The Key Diagnostic Clues
-
Oct 27, 2026, 16:02Ahmad G. Alzahrani: AF and Vascular Risk Factors – Should We Add Antiplatelet Therapy?
-
Oct 27, 2026, 16:02Iron Deficiency and Thrombocytosis: How Iron Availability Shapes Hematopoietic Lineage Decisions
-
Oct 27, 2026, 15:46Christiane Berger-Schaffitzel: New PhD Project Explores Snake Venom and Haemostasis
-
Oct 27, 2026, 13:51Muhammed Hajmusa: ESMO 2026 Highlights the Challenge of Anticoagulation in ROS1-Positive Lung Cancer
-
Oct 27, 2026, 13:39Luca Galassi: Retrieved Venous Thrombi as a Tool for Predicting Post-Thrombotic Syndrome
-
Oct 27, 2026, 11:43Tareq Abadl: Hidden Interferences Behind Unexpected Laboratory Results